United States· US:82868-059_47f9555a-fb69-3042-e063-6394a90aa6cb
Cefdinir
A cefdinir product containing cefdinir, registered in United States by Northwind Health Company, LLC. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Cefdinir is registered in 3 of 19 countries.
Countries holding a registration under ATC J01DD15 (cefdinir), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Cefdinir · ATC J01DD15
3 / 19 countries
- Finlandprice
- Japan
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CEFDINIR
- Manufacturer
- Northwind Health Company, LLC
- Country
- United States (US)
- ATC code
- J01DD15
- ATC class
- Cefdinir
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 5, 2026
Packs & prices · 2
- ndc1182868-059-20
- ndc11828680592020 CAPSULE in 1 BOTTLE, PLASTIC (82868-059-20)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
110 interactions on record for cefdinir.
Graded by severity as the source publishes them — 24 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefdinir · interactions on record
110 records
- 24 moderate
- 86 info
Most severe, free to view
- Magnesium carbonateA02AA01moderate
- Magnesium oxideA02AA02moderate
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefdinir in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ba4c42f5-6ea3-4352-a32e-ff9a6a0edab0 GET /v1/drugs/ba4c42f5-6ea3-4352-a32e-ff9a6a0edab0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "300",
"substance": "CEFDINIR",
"productndc": "82868-059",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA210220",
"marketing_category": "ANDA"
}See everything about cefdinir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.